Skip to main content

Table 1 Clinical Characteristics of Patients with NAFLD and Healthy Controlsa

From: TRIB1 rs17321515 and rs2954029 gene polymorphisms increase the risk of non-alcoholic fatty liver disease in Chinese Han population

 

NAFLD patients (n = 146)

Controls (n = 175)

P Value

Female (%)

65 (44.52)

87 (49.71)

0.353

Age (y)

61.08 ± 15.70

60.15 ± 11.96

0.561

BMI (kg/m2)

26.93 ± 3.85

22.44 ± 2.88

< 0.001

ALT (U/L)

29.95 ± 17.69

22.21 ± 20.63

<  0.001

AST (U/L)

24.22 ± 9.01

22.88 ± 13.03

0.299

GGT (U/L)

39.56 ± 26.48

29.57 ± 36.35

0.006

ALP (U/L)

70.99 ± 16.69

73.75 ± 24.39

0.234

TG (mmol/L)

1.92 ± 1.31

1.33 ± 0.76

< 0.001

TC (mmol/L)

5.47 ± 0.82

4.24 ± 1.39

< 0.001

HDL (mmol/L)

1.20 ± 0.22

1.30 ± 0.37

0.001

LDL (mmol/L)

3.28 ± 0.53

3.11 ± 0.70

0.012

TBIL (umol/L)

13.15 ± 4.67

13.11 ± 5.18

0.942

FPG (mmol/L)

5.62 ± 1.93

4.63 ± 0.84

< 0.001

  1. Abbreviations: BMI body mass index, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT γ-glutamyltransferase, ALP alkaline phosphatase, TG triglyceride, TC total cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein, TBIL total bilirubin, FPG fasting plasma glucose, NAFLD nonalcoholic fatty liver disease
  2. aValues are expressed as mean ± SD and compared by Student’s t-test
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X